"10.1371_journal.pone.0061853","plos one","2013-04-17T00:00:00Z","Eric H Holmes; Harikrishna Devalapally; Libin Li; Michael L Perdue; Gary K Ostrander","Department of Cell and Molecular Biology, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America; Absorption Systems, LP, Exton, Pennsylvania, United States of America; FluSolutions Consulting, LLC, Hilo, Hawaii, United States of America","Conceived and designed the experiments: EHH HD LL MLP GKO. Performed the experiments: EHH HD LL MLP GKO. Analyzed the data: EHH HD LL MLP GKO. Contributed reagents/materials/analysis tools: EHH HD LL MLP GKO. Wrote the paper: EHH HD LL MLP GKO.","The authors have the following interests. The following patent has been applied for: Formulations for enhanced bioavailability of zanamivir, application number PCT/US2011/043587, filed on January 3, 2013, naming EHH and GKO as inventors related to practical applications of this work. The patent has been assigned to Ala Wai Pharma, Inc. in which EHH and GKO have been awarded stock. Co-authors HD and LL are employed by Absorption Systems, LP. Co-author MLP is employed by FluSolutions Consulting, LLC. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Eric H Holmes","EHH",5,TRUE,5,5,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
